Nanozyme-Based Anti-Inflammatory Strategies in Cardiovascular Disease Management: Clinical Prospects and Challenges. [PDF]
Zhou L +6 more
europepmc +1 more source
ABSTRACT Objective To evaluate the efficacy and safety of ofatumumab in patients with myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD), and compare it with rituximab. Methods We conducted a single–center, observational study including 22 MOGAD patients treated with ofatumumab and 21 treated with rituximab.
Yuxin Fan +5 more
wiley +1 more source
A learning health system approach to improving chronic kidney disease management in primary care. [PDF]
Thatcher EJ +6 more
europepmc +1 more source
Safety and Tolerability of Givinostat: Evidence From Real‐World and Clinical Practice
ABSTRACT Objective The aim of our study was to establish the prevalence of adverse events in a real‐world setting in boys living with Duchenne muscular dystrophy (DMD) treated with givinostat as part of an Expanded Access Program (EAP) in Italy. Methods The cohort included 90 ambulant boys, with age when treatment started between 6 and 23 years (mean ...
Marika Pane +19 more
wiley +1 more source
Nasal cytology: Cornerstone and future directions in precision nasal disease management. [PDF]
Zhang Y, Zhang L.
europepmc +1 more source
Management of an important fungal aerial disease of bananas (Black Leaf Streak Disease) without chemical control [PDF]
De Lapeyre de Bellaire, Luc +4 more
core
The DMP atlas for North Rhine-Westphalia, Germany: results of the disease management programmes on district level. [PDF]
Groos S +4 more
europepmc +1 more source
Phytochemicals as potential inhibitors of NETosis: implications for immunothrombosis and chronic disease management. [PDF]
Juanlu C, Chen L, Sung CJ, Hsieh SC.
europepmc +1 more source

